Medical Robots Market

Global Medical Robots Market Size (2024 to 2032)

As per our report, the global medical robots market size is estimated to grow to USD 60.10 billion by 2032 from USD 12.90 billion in 2024, growing at a CAGR of 21.2% during the forecast period. The FDA approval of Vinci X robots developed by Intuitive Surgical was a sensation in the global medical robots market and developed intense competition.

Current Scenario of the Global Medical Robots Market

Robots in the medical sector made all tasks simple, secure, and efficient. Robots are primarily involved in doing surgeries with high precision. The success rate of surgical robots is much higher than that of human surgeons. They can perform surgery even in tiny places accurately by taking more responsibility. The surgeon will have access to operate the robotic arms remotely with a small 3D camera and dime-sized instruments through tiny incisions inside the patient's body parts. Also, medical robots can perform many tasks other than surgeries, like carrying heavy weights and others.

MARKET DRIVERS

The increasing R&D activities by the market participants, the availability of advanced healthcare infrastructure and the rapid adoption of the latest technological advancements are propelling the global medical robots market growth.

Medical robots are specialized robots used for a variety of tasks in the healthcare industry including in the treatment procedures of neurological and orthopedic diseases. Medical robots such as robotic-assisted surgical systems, exoskeleton devices and rehabilitation robots are used in surgical procedures and aid humans suffering from neurological and orthopedic conditions. Rising preference for minimally invasive surgeries, growing adoption of the latest advanced medical technologies and robotics, growing decrepit population, an increase of funding for medical robot research, acceptance the laparoscopic robotics procedures, and development of technologies in medical robotics are further contributing to the growth of the medical robots market. In addition, growing incidences of chronic diseases worldwide and a growing aging population are promoting the need for medical robots.

The growing prevalence of neurological and orthopedic diseases is accelerating the growth rate of the medical robots market. 

The population suffering from neurological diseases such as Alzheimer's disease, Parkinson's disease, and epilepsy is growing rapidly worldwide. WHO says an estimated 50 million people worldwide are suffering from dementia and approximately 10 million new cases are being added. As per the data published by the Parkinson’s Foundation, an estimated 1 million people in the U.S. are suffering from Parkinson’s disease and this number is predicted to hit 1.2 million by 2030. As per the same source, an estimated 10 million people are suffering from Parkinson’s disease. On the other hand, the patient population suffering from orthopedic diseases such as arthritis, osteoporosis, and spinal disorders is growing continuously. As per the information said by the Arthritis Foundation, an estimated 78.4 million adults in the United States are predicted to suffer from doctor-diagnosed arthritis. In recent years, the usage of medical robots in the surgical procedures of neurological and orthopedic diseases has increased tremendously. For instance, medical robots such as the Mazor X robotic surgical system are used for spinal surgery, and the ROSA robot is used for brain surgery.

In addition, the growing number of healthcare centers and increasing patient flow to the hospitals, the government's increasing investments in the pharmaceutical sector to provide effective treatment procedures are further anticipated to project a favorable impact on the market growth. Furthermore, the increasing adoption of medical robots, growing per capita healthcare expenditure in developing emerging countries, and technological advancements in medical robots integrated with surgeon/patient approval for laparoscopic and robotic assistance are promoting the market’s growth rate. Furthermore, with the rise in rehabilitation centers with the help of robot assistance, technological advancements associated with medical robot systems are projected to fuel the medical robots market growth.

MARKET RESTRAINTS

The lack of skilled operators monitoring the medical robotic systems and the growing incidence of system failures in the real-time application due to technical glitches and negligence of staff are hampering the market’s growth rate. In addition, high costs associated with the treatment procedures are also a factor limiting the growth of the market for medical robots.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Medical Robots Market Analysis By Product

The surgical robots segment topped the market and held the largest share of the global medical robots market in 2023 by product type. Compared to human surgeons, the success rate of surgical robots is high, and they can also perform precise surgery in tiny places. It helps disabled patients to improve their mobility and communication. It performs repetitive tasks at high speed and reliably with the help of telemanipulation without fatigue. Very few hospitals can invest in advanced technology instruments, and the hospitals with these medical robots are forced to provide the services at higher rates. The emergence of cloud-based deployment mode in every application is surging the market's growth. The growing acquisition rate of robotic systems in hospitals and the stipulation for minimally invasive surgeries are propelling segmental growth.

The rehabilitation robotic systems segment is another segment that is expected to grow at a significant CAGR during the forecast period. Rehabilitation robotic systems are used for physiotherapy in treating stroke and neurological disorders related to movement disability, which is expected to result in the growth of the segment.

Global Medical Robots Market Analysis By Application

Based on application, the neurological segment had the largest share of the global market in 2023 and is expected to showcase a healthy CAGR during the forecast period. The growth of the segment is primarily driven by the growing neurological disorders such as depression and Alzheimer’s and technological developments for hardware and software of the NeuroMate system in the field of robotic systems, with betterments made in the improved scope of ergonomics.

The orthopedics robotics segment held a noteworthy share of the global market in 2023 and is estimated to register a promising growth rate during the forecast period. The growing number of musculoskeletal conditions, such as rheumatoid arthritis, low back pain, osteoarthritis, and osteoporosis, are propelling segmental growth.

The laparoscopy segment is expected to do well over the forecast period due to the ease of handling the devices; these are mainly designed to meet the surgeons' requirements.

REGIONAL ANALYSIS

The medical robots market in North America has been the most promising regional market globally for the past decade due to the rapid adoption of the latest technologies. In addition, increasing the hospital's construction activities with modern equipment is likely to leverage the demand for medical robots. Also, the growing prevalence of promoting effective treatment concerning the patient’s health prompts the market's need in this region.

The medical robots market in the Asia Pacific is a prominent regional market for medical robots and is estimated to project the fastest CAGR among all the regions. The region’s dominance is majorly driven by the rise in the number of healthcare centers and increasing funds from public and private organizations. The growing adoption of the medical robots market in Asia-Pacific is further propelling regional market growth. Japan, India, and China are expected to have a healthy growth rate in this region. The growing population, rising awareness, growing R&D efforts to enhance the medical robot capabilities and increasing medical robot research funds are further favoring the APAC market growth.

The European market for medical robots is estimated to grow at a notable CAGR during the forecast period owing to the growing number of R&D institutes in the medical sector to spread these applications in various parts. In addition, the growing aging population, increasing demand for minimally invasive surgeries, and advancements in robotics technology are propelling the growth of the medical robots market in the European region. The UK accounted for the major share of the European market in 2023, followed by Germany.

The Latin American medical robots market is expected to see a healthy CAGR in the foreseen years due to the rising incidences of multiple health disorders the increasing need for surgical procedures, and growing economies. 

The medical robots market in the Middle East and Africa is predicted to have a slight inclination in the growth rate during the forecast period. The increasing geriatric population is a significant factor influencing the growth of this market. In addition, the rise in awareness of artificial intelligence applications and their implementation at a high success rate broadens the market demand. In the Middle East and Africa, the medical robotics market is in the transition phase and is experiencing quick shifts toward growth due to factors like the governments' massive capital investments to develop healthcare infrastructure, offering advanced healthcare facilities, and implying attractive health insurance schemes.

KEY PLAYERS IN THE GLOBAL MEDICAL ROBOTS MARKET

Some of the notable companies in the global medical robots market profiled in the report are Intuitive Surgical Inc., Stryker Corporation, Hocoma AG, Mazor Robotics Ltd, Hansen Medical Inc., Accuray Incorporated, Omnicell Inc., Arxium, EKSO Bionics Holdings Inc., and Kirby Lester LLC.

RECENT HAPPENINGS IN THE MARKET

• In February 2020, Omnicell, Inc. announced the essential improvements in clinical trials in ROBOTIC IV insourcing offerings and leveled up Automation Technology investments. 
• In November 2019, Medtronic launched the Mazor X Stealth Edition bringing procedural solutions for surgery plan, implementation, and workflow. Professional surgeons have successfully performed their first spine surgery by using this edition. 
• In August 2019, Capsa Healthcare released Kirby Lester, and it is to provide excellent benefits for hospital patient pharmacies as it does not require technician calibration. Also, this robotic dispenser is to reduce errors while changing medications. 
• In September 2019, Stryker Corporation, a top leading robotics company, made a public statement that it agreed to acquire Mobius Imaging and Cardan robotics to expand the business portfolio.
• In June 2018, FDA approval was received by the Japanese technology company Cyberdyne, which started contributing its HAL (hybrid assistive limb) exoskeleton for legal, medical facilities in the US. To detect electrical signals, movement in a node in the patient’s body was caught by the sensors that are used by the exoskeleton. As a result, physical rehabilitation (lower limb disorders) were provided.

DETAILED SEGMENTATION OF THE GLOBAL MEDICAL ROBOTS INCLUDED IN THIS REPORT

This research report on the global medical robots market has been segmented & sub-segmented based on product, application, and region.

By Product

• Surgical Robots
  • Laparoscopy Robotic Systems
  • Orthopedic Robotic Systems
  • Neurosurgical Robotic Systems
  • Steerable Robotic Systems
• Rehabilitation Robotic Systems
  • Therapeutic Robotic Systems
  • Assistive Robotic Systems
  • Prosthetic Robotic Systems
  • Orthotic Robotic Systems
  • Exoskeleton Robotic Systems
• Non-Invasive Radiosurgery Robotic Systems
• Hospital And Pharmacy Robotic Systems
  • Pharmacy Robotic Systems
  • Iv Robotic Systems
  • Telemedicine Robots

By Application

• Laparoscopy
• Orthopedics
• Neurology
• Special Education

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa